Navigation Links
Treating eye diseases with anti-VEGF therapies may have side effects
Date:1/11/2013

Rockville, MD A new Investigative Ophthalmology & Visual Science (IOVS) article reveals that increasingly aggressive therapies that block VEGF could cause damage in treating eye diseases. Scientists discovered inhibiting anti-VEGF might have a harmful effect on the tissue responsible for producing the fluid that bathes the eye, medically termed the ciliary body.

"Very little is known about the factors that regulate the integrity and function of this tissue [the ciliary body] in the adult," said author Patricia A. D'Amore, PhD, of Schepens Eye Research Institute/Massachusetts Eye and Ear. "Our finding indicates that VEGF-A is at least one of the molecules that play a role in keeping the ciliary body healthy and functioning properly."

In the study, Expression and role of VEGF-A in the Ciliary Body, investigators simulated the VEGF-A activity in adult mice and found that blocking the protein decreased the intraocular pressure, an unexpected side effect that impaired the ciliary body.

Several anti-VEGF-A therapies are currently being widely and successfully used for the treatment of eye diseases like wet macular degeneration, diabetic macular edema and retinopathy of prematurity. D'Amore agrees that there is no evidence to indicate that the manner in which these drugs are being administered interferes with the ciliary body. "However, there is a move toward developing methods to continuously deliver anti-VEGF to the eye and to have drugs that are more potent inhibitors of VEGF," she said. "I would be concerned that more aggressive VEGF inhibition in the eye would have deleterious effects on the ciliary body."

The research team's investigation of anti-VEGF-A on the ciliary body was the result of prior studies that found blocking VEGF can lead to the degeneration of capillary beds, particularly capillaries that have specializations called fenestrations like the ones found in the ciliary body. These include whole body VEGF bl
'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study Suggests Treating Dyslexia Before Kids Learn to Read
2. New standards for treating traumatic shoulder injuries to improve patient care
3. Treating childhood obesity: A family affair
4. Unique physiology key to diagnosing and treating diabetes in Asian populations
5. Studies See Advances in Detecting, Treating Pancreatic Cancer
6. 1 size doesnt fit all when treating blood pressure in people with diabetes, VA/U-M study suggests
7. Nanomedicines promise fewer side effects in treating cancer
8. Mount Sinai researchers develop a multi-target approach to treating tumors
9. A non-antibiotic approach for treating urinary tract infections
10. UT Southwestern study shows treating diabetes early, intensively is best strategy
11. Researchers report success in treating autism spectrum disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... SafeUseNow? , a prescription drug ... Principled Strategies , today announced a service ... Utilizing SafeUseNow’s patent-pending risk model, Partnership HealthPlan can ... abusing controlled substance drugs, particularly prescription opioids, helping ... , The agreement with Partnership HealthPlan was made ...
(Date:7/23/2014)... 23, 2014 “North America Cardiovascular ... market data on the North America Cardiovascular Prosthetic ... of US dollars, and volume (in units) and ... categories Cardiac Valve Repairs and Septal Occluders. , ... shares data for each of these market categories, ...
(Date:7/23/2014)... dyes, George Mason University researchers discovered an innovative ... possibly leading to new treatments for cancer, arthritis, ... Mason researchers unraveled the mystery of deciphering the ... protein interlocks with another protein like adjacent pieces ... signal down the line to the next protein," ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 ... collaboration, today announce that it has joined the ... interoperability between Splashtop Enterprise and RSA SecurID® multi-factor ... EMC (EMC). , Splashtop also announced ... is now deploying Splashtop Enterprise, the industry’s only ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 On July 21, ... childhood safety advocate Jack Tracey for an episode that spoke ... the episode, Deierlein asks Tracey to talk some about the ... international in its mission, it was started right here in ... initially it was to help survivors of sexual abuse. Their ...
Breaking Medicine News(10 mins):Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Researchers unlock the protein puzzle 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2
... Engineers have developed a new type of microchip muscle stimulator ... paralysed leg muscles. It is the first time ... is small enough to be implanted into the spinal canal ... The implant is the size of a child,s fingernail. ...
... have become aware of the dangers of excessive fructose in ... of the Journal of the American Society of Nephrology ... sugar may be. Richard J. Johnson, MD and ... of Colorado) provide a concise overview of recent clinical and ...
... Nov. 22 (HealthDay News) -- Women who were sexually or ... problems, researchers say. In the study, researchers analyzed data ... U.S. National Alcohol Survey. The investigators found that women who ... more likely to also report that they drank four or ...
... , MONDAY, Nov. 22 (HealthDay News) -- The approximately ... each year in the United States cost the health care ... Control and Prevention said in its annual STD report released ... burden of STDs but there are some signs of progress, ...
... EDITOR,S PICK: Who is in your poo? ... Pamer, Carles Ubdea, and colleagues, at Memorial Sloan-Kettering ... suggest that high-throughput DNA sequencing of bacteria in ... life-threatening bloodstream infection with the antibiotic-resistant bacterium vancomycin-resistant ...
... Alexandria, Va. The American Association for Dental Research (AADR) ... the Washington, DC, area. This year, the theme was the ... & Clinical Frontiers. The symposium was sold-out, but AADR also ... AADR created the Fall Focused Symposium under the objective ...
Cached Medicine News:Health News:New spinal implant will help people with paraplegia to exercise paralyzed limbs 2Health News:Girls Who Suffer Child Abuse May Abuse Alcohol as Adults 2Health News:New STD Report Finds Some Progress, High Costs for U.S. 2Health News:JCI table of contents: Nov. 22, 2010 2Health News:JCI table of contents: Nov. 22, 2010 3Health News:JCI table of contents: Nov. 22, 2010 4Health News:JCI table of contents: Nov. 22, 2010 5Health News:JCI table of contents: Nov. 22, 2010 6Health News:JCI table of contents: Nov. 22, 2010 7Health News:JCI table of contents: Nov. 22, 2010 8Health News:JCI table of contents: Nov. 22, 2010 9Health News:JCI table of contents: Nov. 22, 2010 10Health News:JCI table of contents: Nov. 22, 2010 11Health News:JCI table of contents: Nov. 22, 2010 12Health News:Cutting-edge salivary diagnostics research presented at AADR 3rd Fall Focused Symposium 2
(Date:7/23/2014)... -- On Tuesday, July 1, 2014, Eclipse ... 116 th Judicial District Court in ... USA, LLC ("Defendant") for Tortious Interference ... false and misleading actions, fraud, fraud-in-the-inducement, business interference, ... libel, disparagement, defamation, misrepresentation, and violating the false/deceptive ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & ... Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership ... Effective August 1, WVMI will launch Quality Insights ... , Pennsylvania , Delaware ... Louisiana.  The Network will engage providers and the community ...
(Date:7/23/2014)... SAN DIEGO , July 23, 2014  RT ... has agreed to join its board of directors. ... of Microsoft Corporation, where he works on strategic projects ... Previously, he was Microsoft,s chief research and strategy officer. ... chief executive officer of RainTree, said, "Craig is a ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... VacChina 2011 - - ... - - welcomes world class ... vaccine R&D and manufacturing technologies in China. The ... national regulatory authority of China -- the State Food and Drug ...
... Aug. 18, 2011 Generex Biotechnology Corporation (OTCBB: ... Company,s wholly-owned subsidiary Antigen Express, Inc. ( www.antigenexpress.com ... 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, ... Healthtech Institute,s Sixth Annual ImVacS: The Immunotherapeutics and ...
Cached Medicine Technology:VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 3Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 4
Townsend is a endocervical stainless-steel curette with round tapered tip....
...
...
...
Medicine Products: